Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:focusArea |
Neuroscience
Oncology Immunology Infectious diseases Cardiovascular diseases |
| gptkbp:foundedYear |
1953
|
| gptkbp:founder |
gptkb:Paul_Janssen
|
| gptkbp:headquartersLocation |
gptkb:Beerse,_Belgium
|
| https://www.w3.org/2000/01/rdf-schema#label |
Janssen Sciences
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Sirturo
gptkb:Symtuza gptkb:Edurant gptkb:Prezista gptkb:Risperdal gptkb:Spravato gptkb:Imbruvica gptkb:Darzalex gptkb:Stelara |
| gptkbp:operatesIn |
Global
|
| gptkbp:parentCompany |
gptkb:Johnson_&_Johnson
|
| gptkbp:products |
Pharmaceutical drugs
|
| gptkbp:subsidiary |
gptkb:Johnson_&_Johnson
|
| gptkbp:type |
gptkb:subsidiary
|
| gptkbp:website |
https://www.janssen.com/
|
| gptkbp:bfsParent |
gptkb:Ringaskiddy
|
| gptkbp:bfsLayer |
6
|